Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-10

AUTHORS

Katsunori Yonekura, Yoko Eto, Ikuo Yokoyama, Akihiro Matsumoto, Seiryo Sugiura, Shin-ichi Momomura, Tsukasa Kirimoto, Yukio Hayashi, Masao Omata, Teruhiko Aoyagi

ABSTRACT

It was previously reported than inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29% lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI. More... »

PAGES

343-348

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s003950070032

DOI

http://dx.doi.org/10.1007/s003950070032

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044619516

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11099160


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium-Transporting ATPases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carnitine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hexokinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoenzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methylhydrazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sarcoplasmic Reticulum Calcium-Transporting ATPases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yonekura", 
        "givenName": "Katsunori", 
        "id": "sg:person.0746234355.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746234355.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eto", 
        "givenName": "Yoko", 
        "id": "sg:person.01047361177.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047361177.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoyama", 
        "givenName": "Ikuo", 
        "id": "sg:person.01355412055.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355412055.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsumoto", 
        "givenName": "Akihiro", 
        "id": "sg:person.01235416167.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235416167.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugiura", 
        "givenName": "Seiryo", 
        "id": "sg:person.01277502614.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277502614.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Momomura", 
        "givenName": "Shin-ichi", 
        "id": "sg:person.01242732453.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242732453.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.419828.e", 
          "name": [
            "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirimoto", 
        "givenName": "Tsukasa", 
        "id": "sg:person.01301742751.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301742751.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.419828.e", 
          "name": [
            "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hayashi", 
        "givenName": "Yukio", 
        "id": "sg:person.01251615631.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251615631.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Omata", 
        "givenName": "Masao", 
        "id": "sg:person.0775700471.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aoyagi", 
        "givenName": "Teruhiko", 
        "id": "sg:person.010646460075.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010646460075.48"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2000-10", 
    "datePublishedReg": "2000-10-01", 
    "description": "Abstract It was previously reported than inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29% lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s003950070032", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1016443", 
        "issn": [
          "0300-8428", 
          "1435-1803"
        ], 
        "name": "Basic Research in Cardiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "95"
      }
    ], 
    "keywords": [
      "myocardial infarction", 
      "sarcoplasmic reticulum Ca2", 
      "carnitine synthesis", 
      "MI group", 
      "control group underwent sham surgery", 
      "MET-88", 
      "control group", 
      "reticulum Ca2", 
      "myocardial protein content", 
      "underwent sham surgery", 
      "coronary artery ligation", 
      "same rat model", 
      "cardiac sarcoplasmic reticulum Ca2", 
      "ventricular systolic", 
      "diastolic function", 
      "heart failure", 
      "sham surgery", 
      "artery ligation", 
      "hemodynamic dysfunction", 
      "rat model", 
      "tissue damage", 
      "rat heart", 
      "myocardial homogenates", 
      "glucose utilization", 
      "hexokinase type I", 
      "placebo", 
      "infarction", 
      "protein content", 
      "rats", 
      "type I", 
      "SERCA2", 
      "inhibition", 
      "group", 
      "possible mechanism", 
      "uptake function", 
      "Ca2", 
      "systolic", 
      "surgery", 
      "dysfunction", 
      "key enzyme", 
      "depression", 
      "ligation", 
      "homogenates", 
      "heart", 
      "ATPase", 
      "days", 
      "failure", 
      "damage", 
      "function", 
      "hexokinase", 
      "control", 
      "contrast", 
      "preservation", 
      "effect", 
      "enzyme", 
      "hypothesis", 
      "mechanism", 
      "content", 
      "synthesis", 
      "utilization", 
      "Abstract", 
      "model"
    ], 
    "name": "Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction", 
    "pagination": "343-348", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044619516"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s003950070032"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11099160"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s003950070032", 
      "https://app.dimensions.ai/details/publication/pub.1044619516"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_317.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s003950070032"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      102 URIs      94 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s003950070032 schema:about N464c44633c0e40cfa0887c00c546200c
2 N570b4b7b8fb94ae0aafd24bfa6d1a51a
3 N6b83928557d0495496e016d848d07d37
4 N6fd576b3ef5249fabcad9495f7c390c4
5 N7774cd0a458347ec8cd8332c48ec8a77
6 N77e6b4b95175499387a52821d686a90c
7 N9befe6a46f2343c39089a3514143ba56
8 Na8592c822f064189ab64b1c2c09fd230
9 Naa5795bc86b44e5cbd804b7beb4e4b7f
10 Naaa91c2d60bf4a9a9a3addebaf3cd9ed
11 Nb266effa79b0422cb5f84f49855a30d2
12 Ne302d5ead63e485e9d4be8dac018c140
13 Nf8cdea49a40247a980a4313bc7483a2b
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author N4c63d5be9b9b44988dc7b1d469ab1e70
17 schema:datePublished 2000-10
18 schema:datePublishedReg 2000-10-01
19 schema:description Abstract It was previously reported than inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29% lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree false
23 schema:isPartOf N7349b162fd3f46b8a2a7dd95e16c712f
24 N93c6db36b136493a919246445a4bbd9d
25 sg:journal.1016443
26 schema:keywords ATPase
27 Abstract
28 Ca2
29 MET-88
30 MI group
31 SERCA2
32 artery ligation
33 cardiac sarcoplasmic reticulum Ca2
34 carnitine synthesis
35 content
36 contrast
37 control
38 control group
39 control group underwent sham surgery
40 coronary artery ligation
41 damage
42 days
43 depression
44 diastolic function
45 dysfunction
46 effect
47 enzyme
48 failure
49 function
50 glucose utilization
51 group
52 heart
53 heart failure
54 hemodynamic dysfunction
55 hexokinase
56 hexokinase type I
57 homogenates
58 hypothesis
59 infarction
60 inhibition
61 key enzyme
62 ligation
63 mechanism
64 model
65 myocardial homogenates
66 myocardial infarction
67 myocardial protein content
68 placebo
69 possible mechanism
70 preservation
71 protein content
72 rat heart
73 rat model
74 rats
75 reticulum Ca2
76 same rat model
77 sarcoplasmic reticulum Ca2
78 sham surgery
79 surgery
80 synthesis
81 systolic
82 tissue damage
83 type I
84 underwent sham surgery
85 uptake function
86 utilization
87 ventricular systolic
88 schema:name Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction
89 schema:pagination 343-348
90 schema:productId N0373ea28c8504e2aabcfc3cd64cec3fc
91 N1c5ba12422aa49ab8cd3234fa48c9dff
92 N893ef29be07148eab967f6ce7e8a183b
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044619516
94 https://doi.org/10.1007/s003950070032
95 schema:sdDatePublished 2022-05-20T07:21
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher N96b7006327934ca18960c01182baf034
98 schema:url https://doi.org/10.1007/s003950070032
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N0373ea28c8504e2aabcfc3cd64cec3fc schema:name dimensions_id
103 schema:value pub.1044619516
104 rdf:type schema:PropertyValue
105 N1c5ba12422aa49ab8cd3234fa48c9dff schema:name pubmed_id
106 schema:value 11099160
107 rdf:type schema:PropertyValue
108 N45ae171a8c3c4816aeeb043fa3f180d1 rdf:first sg:person.010646460075.48
109 rdf:rest rdf:nil
110 N464c44633c0e40cfa0887c00c546200c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Methylhydrazines
112 rdf:type schema:DefinedTerm
113 N4c63d5be9b9b44988dc7b1d469ab1e70 rdf:first sg:person.0746234355.31
114 rdf:rest Nd8d4438fd17a4168bda23de2b14b6b16
115 N570b4b7b8fb94ae0aafd24bfa6d1a51a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Myocardium
117 rdf:type schema:DefinedTerm
118 N5c35b7413f534e4d8b2bb5a23707f27a rdf:first sg:person.01235416167.92
119 rdf:rest N7f29a4aa1e9346c5b333bddd043f376a
120 N5f31139dc2a344a3a57885dda85206a2 rdf:first sg:person.01355412055.69
121 rdf:rest N5c35b7413f534e4d8b2bb5a23707f27a
122 N6b83928557d0495496e016d848d07d37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hexokinase
124 rdf:type schema:DefinedTerm
125 N6fd576b3ef5249fabcad9495f7c390c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cardiovascular Agents
127 rdf:type schema:DefinedTerm
128 N7349b162fd3f46b8a2a7dd95e16c712f schema:issueNumber 5
129 rdf:type schema:PublicationIssue
130 N75839f76dd5d4a66a24f52f890cbfe1c rdf:first sg:person.01251615631.78
131 rdf:rest Na8be9b9fae11463fac9f75b89ef5b7ac
132 N7774cd0a458347ec8cd8332c48ec8a77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Animals
134 rdf:type schema:DefinedTerm
135 N77e6b4b95175499387a52821d686a90c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Rats
137 rdf:type schema:DefinedTerm
138 N7f29a4aa1e9346c5b333bddd043f376a rdf:first sg:person.01277502614.69
139 rdf:rest Nf8f87738cf9345a4a40d486a1c2e3226
140 N893ef29be07148eab967f6ce7e8a183b schema:name doi
141 schema:value 10.1007/s003950070032
142 rdf:type schema:PropertyValue
143 N93c6db36b136493a919246445a4bbd9d schema:volumeNumber 95
144 rdf:type schema:PublicationVolume
145 N96b7006327934ca18960c01182baf034 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N98636f631bb44fe29a9bff8e3bef67e4 rdf:first sg:person.01301742751.82
148 rdf:rest N75839f76dd5d4a66a24f52f890cbfe1c
149 N9befe6a46f2343c39089a3514143ba56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Rats, Sprague-Dawley
151 rdf:type schema:DefinedTerm
152 Na8592c822f064189ab64b1c2c09fd230 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Myocardial Infarction
154 rdf:type schema:DefinedTerm
155 Na8be9b9fae11463fac9f75b89ef5b7ac rdf:first sg:person.0775700471.08
156 rdf:rest N45ae171a8c3c4816aeeb043fa3f180d1
157 Naa5795bc86b44e5cbd804b7beb4e4b7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Male
159 rdf:type schema:DefinedTerm
160 Naaa91c2d60bf4a9a9a3addebaf3cd9ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Sarcoplasmic Reticulum Calcium-Transporting ATPases
162 rdf:type schema:DefinedTerm
163 Nb266effa79b0422cb5f84f49855a30d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Carnitine
165 rdf:type schema:DefinedTerm
166 Nd8d4438fd17a4168bda23de2b14b6b16 rdf:first sg:person.01047361177.42
167 rdf:rest N5f31139dc2a344a3a57885dda85206a2
168 Ne302d5ead63e485e9d4be8dac018c140 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Isoenzymes
170 rdf:type schema:DefinedTerm
171 Nf8cdea49a40247a980a4313bc7483a2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Calcium-Transporting ATPases
173 rdf:type schema:DefinedTerm
174 Nf8f87738cf9345a4a40d486a1c2e3226 rdf:first sg:person.01242732453.82
175 rdf:rest N98636f631bb44fe29a9bff8e3bef67e4
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
180 schema:name Cardiorespiratory Medicine and Haematology
181 rdf:type schema:DefinedTerm
182 sg:journal.1016443 schema:issn 0300-8428
183 1435-1803
184 schema:name Basic Research in Cardiology
185 schema:publisher Springer Nature
186 rdf:type schema:Periodical
187 sg:person.01047361177.42 schema:affiliation grid-institutes:grid.26999.3d
188 schema:familyName Eto
189 schema:givenName Yoko
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047361177.42
191 rdf:type schema:Person
192 sg:person.010646460075.48 schema:affiliation grid-institutes:grid.26999.3d
193 schema:familyName Aoyagi
194 schema:givenName Teruhiko
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010646460075.48
196 rdf:type schema:Person
197 sg:person.01235416167.92 schema:affiliation grid-institutes:grid.26999.3d
198 schema:familyName Matsumoto
199 schema:givenName Akihiro
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235416167.92
201 rdf:type schema:Person
202 sg:person.01242732453.82 schema:affiliation grid-institutes:grid.26999.3d
203 schema:familyName Momomura
204 schema:givenName Shin-ichi
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242732453.82
206 rdf:type schema:Person
207 sg:person.01251615631.78 schema:affiliation grid-institutes:grid.419828.e
208 schema:familyName Hayashi
209 schema:givenName Yukio
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251615631.78
211 rdf:type schema:Person
212 sg:person.01277502614.69 schema:affiliation grid-institutes:grid.26999.3d
213 schema:familyName Sugiura
214 schema:givenName Seiryo
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277502614.69
216 rdf:type schema:Person
217 sg:person.01301742751.82 schema:affiliation grid-institutes:grid.419828.e
218 schema:familyName Kirimoto
219 schema:givenName Tsukasa
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301742751.82
221 rdf:type schema:Person
222 sg:person.01355412055.69 schema:affiliation grid-institutes:grid.26999.3d
223 schema:familyName Yokoyama
224 schema:givenName Ikuo
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355412055.69
226 rdf:type schema:Person
227 sg:person.0746234355.31 schema:affiliation grid-institutes:grid.26999.3d
228 schema:familyName Yonekura
229 schema:givenName Katsunori
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746234355.31
231 rdf:type schema:Person
232 sg:person.0775700471.08 schema:affiliation grid-institutes:grid.26999.3d
233 schema:familyName Omata
234 schema:givenName Masao
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08
236 rdf:type schema:Person
237 grid-institutes:grid.26999.3d schema:alternateName Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP
238 schema:name Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP
239 rdf:type schema:Organization
240 grid-institutes:grid.419828.e schema:alternateName Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP
241 schema:name Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...